Abstract
The development of enzyme-based self-labeling tags allow the labeling of proteins in living cells with synthetic small-molecules. Use of a fluorophore-containing ligand enables the visualization of protein location inside cells using fluorescence microscopy. Alternatively, deployment of a biotin-containing ligand allows purification of tagged protein using affinity resins. Despite these various applications of self-labeling tags, most ligands serve a single purpose. Here, we describe self-labeling tag ligands that allow both visualization and subsequent capture of a protein. A key design principle is exploiting the chemical properties and size of a rhodamine fluorophore to optimize cell-permeability of the ligand and the capture efficiency of the biotin conjugate. This work generates useful “multifunctional” fluorophores with generalizable design principles that will allow the construction of new tools for biology.
Introduction
Advances in the understanding of biological processes rely on the ability to visualize and manipulate biomolecules inside cells. Research at the interface of synthetic organic chemistry and protein biochemistry has generated powerful tools to probe and perturb cells with molecular specificity1. In particular, the engineering of enzyme–substrate interactions produced self-labeling tags such as the HaloTag2 or SNAP-tag3. These protein tags react specifically and irreversibly with a ligand motif that can be appended with a variety of functionalities including affinity tags for purification and fluorescent dyes for visualization (Figure 1a)4. In addition to intracellular labeling experiments, self-labeling tags can also serve as a robust scaffold for indicators5, 6 and integrators7 of cellular activity.
Despite the generality of self-labeling tags, the current portfolio of ligands suffers from limitations. Most ligands serve a single function—for example to probe or purify the tagged protein. Second, each combination of functional small-molecule, linker, and ligand moiety has distinct chemical properties that can affect the cell permeability and labeling kinetics of the ligand, and the properties of the resulting protein conjugate8. For the development of the HaloTag system, the directed evolution approach utilized a 1-chlorohexane ligand attached to a 6-carboxytetramethylrhodamine (TMR) via a short polyethylene glycol (PEG) linker2. This TMR-HaloTag ligand (1, Figure 1b) is cell-permeable, exhibits rapid labeling kinetics with the HaloTag, and results in a close association of the TMR moiety and the surface of the protein (Figure 1c; PDB: 6U32). This intimate dye–protein contact can elicit modest improvements in fluorophore photophysics, but for other moieties this close association of protein and ligand can be detrimental, requiring the incorporation of longer linkers that can affect cell-permeability and other ligand properties.
Given the common tug-of-war between functionality and biocompatibility in small-molecule ligand development, we envisioned a new strategy to create cell-permeable probes by utilizing a rhodamine fluorophore as a linker for self-labeling tag ligands (Figure 1d). This idea was predicated on several factors. First, as mentioned above, the directed evolution of the HaloTag utilized TMR-based ligand 1, and rhodamine-based HaloTag ligands generally show rapid labeling kinetics8. Second, the ability to fine-tune the chemical and spectral properties of rhodamine dyes could allow optimization of the cell-permeability or other properties of the ligand9-12. Finally, the insertion of a fluorescent species enables visualization of the molecule inside cells, allowing verification of the compound’s performance using fluorescence imaging. Here, we describe our design and optimization of fluorophore ligands bearing a biotin that is both cell-permeable and useful for subsequent purification of HaloTag fusion proteins. These modular “multifunctional fluorophores” represent a new facet of dye-based tools for biology and this strategy should be generalizable to other functional motifs.
Results AND Discussion
Evaluation of biotin-HaloTag ligand
We first evaluated HaloTag ligands bearing biotin given the broad utility of the high-affinity biotin–streptavidin interaction in biochemistry and cell biology. To test these compounds, we developed an assay where the HaloTag is expressed as a fusion with monomeric superfolder green fluorescent protein (msGFP); the construct also included an OMP25 sequence to localize the fusion protein to the outer mitochondrial membrane allowing straightforward imaging and protein capture experiments13, 14. Cells expressing this fusion protein were incubated with biotin-containing HaloTag ligands followed by washing and cell lysis. The crude supernatant was incubated with streptavidin-coated magnetic microbeads, applied to a column and the elution fractions were analyzed by SDS–PAGE and in-gel fluorescence (Figure 2a). We first tested the commercial biotin-HaloTag ligand (2, Figure 2b), which has the standard HaloTag ligand found in compound 1 (Figure 1b) directly attached to the biotin carboxyl group. Pulse–chase experiments revealed compound 2 is modestly membrane permeable and can label the HaloTag–msGFP fusion in living cells when applied at μM concentrations (Supplementary Figure 1). The standard PEG2 linker in compound 2 is too short to allow binding of the biotin– HaloTag conjugate to streptavidin, however, which prevents purification of HaloTag fusion proteins from cells using streptavidin (Figure 2c–d). Unfortunately, attempts to remedy this problem by incorporating a longer PEG linker yields a molecule with no detectable cell permeability, thereby rendering it unsuitable for live-cell experiments15.
Design and synthesis of biotin-containing multifunctional fluorophores
We posited the problems with the extant biotin-containing HaloTag ligands could be remedied by incorporating a rhodamine linker into the chemical structure. For base rhodamine dyes, we envisaged utilizing the Janelia Fluor (JF) dyes JF549 (3), JF646, (4), and JF635 (5, Figure 3a). JF549 (3) is structurally similar to TMR, but contains four-membered azetidine rings in place of the N,N-dimethylamino groups; this net increase of two carbon atoms greatly increases brightness and photostability16. JF646 (4) is a Si-rhodamine where the xanthene oxygen in 3 is replaced with a dimethylsilicon group17, 18. This substitution elicits a substantial ∼100 nm bathochromic shift in absorption maxima (λabs) and fluorescence emission maxima (λem). JF635 (5) contains 3-fluoroazetidine substituents that fine-tune the properties of the Si-rhodamine molecule, eliciting a modest 11-nm hypsochromic shift in both λabs and λ em9.
A key property of rhodamine dyes is an equilibrium between a nonfluorescent lactone (L) and fluorescent zwitterion (Z; Figure 3a). This equilibrium dictates the performance of dyes in biological systems. In previous work, we developed a general rubric linking the lactone–zwitterion equilibrium constant (KL–Z) of the JF dyes with properties such as cell permeability and fluorogenicity19. In addition to modulating spectral characteristics, chemical substitutions can also affect KL–Z. JF549 (3) has a relatively high KL–Z = 3.45 so it preferentially adopts the zwitterionic form. The dimethylsilicon substitution in JF646 (4) causes a large shift in equilibrium toward the nonfluorescent lactone form (KL–Z = 0.0014). The electron-withdrawing fluorines in JF635 (5) further shift this equilibrium (KL–Z = 0.0001), yielding a dye with low visible absorption even in polar media such as water. Together, this series of dyes represent different foundational chemical properties to test if rhodamine moieties could be used to improve cell permeability.
We then considered the installation of the biotin group. In addition to improving brightness and allowing fine-tuning of spectral properties and KL–Z (e.g., JF635, 5), the azetidine motif also allows facile conjugation of chemical groups using 3-carboxyazetidine derivatives. In previous work, we attached the Ca2+ chelator BAPTA to prepare localizable calcium ion indicators5. Using this strategy, we synthesized the biotin-JF-HaloTag ligand compounds 6–8 (Figure 3b). The biotin-JF549-HaloTag ligand (6) and biotin-JF646-HaloTag ligand (7) were prepared by conjugating the known 3-carboxyazetidine compounds 9 and 10 with the commercially available biotin-PEG2-NH2 (11; Scheme 1a). The JF635 derivative 8 was synthesized starting from the Si-fluorescein ditriflate derivative 12 (Scheme 1b). Sequential palladium-catalyzed C–N cross-coupling reactions first with 3-fluoroazetidine (13) to generate 14, followed by 3-carboxyazetidine methyl ester (15) generated Si-rhodamine 16 in 55% yield over two steps. Subsequent deprotection of the t-butyl ester by trifluoroacetic acid (TFA) generated the carboxy-containing dye 17, which was coupled to the standard HaloTag ligand amine 18 to yield compound 19. This was followed by mild saponification of the methyl ester to afford compound 20 in 61% yield over three steps. Finally, amide coupling of 20 and biotin-PEG2-NH2 (11) afforded biotin-JF635-HaloTag ligand (8) in 28% yield.
Cellular experiments with biotin-containing ligands
We then tested the biotin conjugates in cellular experiments, starting with the biotin-JF549-HaloTag ligand (6), comparing this to the standard HaloTag ligand of JF549 (21, Figure 4a). Although the parent compound 21 labeled the mitochondria-localized HaloTag-msGFP fusions inside cells (Figure 4b–c), the biotin-containing ligand 6 did not show appreciable cellular labeling measured using fluorescence microscopy (Figure 4d–e, Supplementary Figure 2). This result demonstrates that the proclivity of JF549 to adopt the polar zwitterionic form (KL–Z = 3.5, Figure 3a) combined with the hydrophilic biotin– PEG functionality yields a molecule that exhibits low membrane permeability in cellular experiments.
We then tested the biotin-JF646-HaloTag ligand (7) and parent JF646-HaloTag ligand (22; Figure 5a). As expected, fluorescence microscopy experiments revealed that the established JF646 ligand 22 labeled the HaloTag-msGFP fusion protein inside cells (Figure 5b–c). In contrast to the JF549 compound 6 (Figure 4d–e), however, the biotin-containing JF646 ligand 7 also labeled proteins inside cells at nM concentration (Figure 5d–e); incubation of live cells with the ligand gave almost immediate far-red cellular fluorescence. The biotin-JF635-HaloTag ligand (8) and the unsubstituted JF635-HaloTag ligand (23; Figure 5f) gave different results. Relatively bright labeling of mitochondria was observed with the parent ligand 23 (Figure 5g–h), but the signal from cells incubated with biotin-JF635 ligand 8 was lower (Figure 5i–j). The imaging experiments using biotin-JF-HaloTag ligands 7–8 and JF-HaloTag ligands 22–23 were repeated and quantified (Figure 5k), showing that the two JF646 ligands exhibit similar average intensities. For the JF635 derived compounds, the biotinylated 8 showed lower fluorescence intensity than the unmodified ligand 23; both JF635 compounds exhibited lower intensity than the JF646 compounds.
We then tested the efficiency of labeling by cell lysis and capture of biotin-labeled protein using streptavidin beads (Figure 5l). As expected, the use of the non-biotinylated JF635-HaloTag ligand (23) gave no appreciable protein capture. Use of the biotin-JF635-HaloTag ligand (8), however, showed efficient labeling of protein, yielding a capture efficiency of 45%; this was equivalent to the capture efficiency of the biotin-JF646-HaloTag ligand (7; Figure 5l–m).
This result was inconsistent with the different fluorescence intensities observed in cells using the two biotin ligands (Figure 5d, 5i). To resolve this discrepancy, we measured the absorbance of 7 and 8 in the absence (-HT) or presence (+HT) of excess purified HaloTag protein (Figure 5n). For the JF646 ligand 7, we observed relatively high absorptivity in the unbound state; attachment to the HaloTag protein increased the absorption two-fold. For the JF635 compound 8, the free ligand showed relatively low absorption in solution and showed a substantial, 10-fold increase upon conjugation to the HaloTag protein but with an overall lower absorbance compared to JF646 ligand 7. These results show that the JF635 ligand 8 is highly chromogenic and fluorogenic, but has lower absolute absorptivity compared to the JF646 ligand 7 in the HaloTag-bound state, leading to lower fluorescence intensity in cells. Overall, this demonstrates that both Si-rhodamine-based biotin-JF-HaloTag ligands 7 and 8 enter cells, efficiently label HaloTag proteins, and present a biotin moiety that is accessible to streptavidin affinity resins for protein capture.
Conclusion
The ability to specifically label proteins with synthetic small-molecules inside living cells is a powerful technique for biology. In particular, the development of fluorescent ligands for self-labeling tags has enabled advanced imaging experiments. Most synthetic ligands only serve a single purpose, however, and many compounds suffer from poor cell-permeability. We addressed these issues through the rational design of multifunctional dyes that contain both a rhodamine fluorophore and a biotin affinity reagent. A critical element in our molecular design was to exploit the different chemical properties of rhodamine dyes to give functional biotin derivatives with high cell permeability. Looking forward, this strategy of “rhodamine-as-linker” should permit the creation of superior tools for cell biology, allowing a single compound to serve as both a fluorescent label and protein manipulator.
Author Contributions
The authors collectively conceived the project. P.K. contributed organic synthesis. J.D.V. contributed cultured cell imaging and biochemical experiments. L.D.L contributed spectroscopy measurements. L.D.L. and E.R.C. directed the project. P.K. and L.D.L. wrote the paper with input from the other authors.
Acknowledgements
We thank A. Tebo and A. Waring (Janelia) for purified HaloTag protein. This work was supported by grants from the National Institutes of Health (MH061876 and NS097362 to E.R.C.) and the Howard Hughes Medical Institute. E.R.C. is an investigator of the Howard Hughes Medical Institute. J.D.V. was supported by a postdoctoral fellowship from the National Institutes of Health (F32 NS098604) and the Warren Alpert Distinguished Scholars Fellowship award.